May 01, 2024

The use of DN to the muscular trigger points and distal periosteal enthesis of the levator scapulae may be a useful adjunct intervention within a multi-modal plan of care for the management of work-re...

Feb 18, 2024

This review summarizes the evolution in diagnosis, evaluation, and treatment of primary headache associated with sexual activity (PHASA).Despite increased access to patient information and advances in...

Sep 01, 2023

To evaluate the efficacy and safety of ubrogepant for the acute treatment of perimenstrual migraine (pmM) attacks.Ubrogepant is an oral calcitonin gene-related peptide receptor antagonist approved for...

Jul 25, 2023

Migraine headache attacks and accompanying sensory augmentation can be induced by several agents including levcromakalim (LVC), that is also capable of provoking aura-like symptoms in migraineurs. We ...

May 29, 2023

Migraine is one of the most disabling disorders in the world, associated with poor quality of life. Migraine prevention strategies have increasingly evolved since monoclonal antibodies against the cal...

May 29, 2023

Migraine-a painful, throbbing headache disorder-is the most common complex brain disorder, yet its molecular mechanisms remain unclear. Genome-wide association studies (GWAS) have proven successful in...

May 22, 2023

Migraine patients are frequently affected by sleep complaints. The ketogenic diet (KD) is an option for the treatment of migraine. Our aim was: 1) to assess the effects of KD on sleep complaints in pa...

May 22, 2023

No acute treatments targeting calcitonin gene-related peptide (CGRP) have been approved for use in China or South Korea. We aimed to compare the efficacy and safety of rimegepant-an orally administere...

May 16, 2023

Using a headache duration of 30 or more minutes, rather than 4 or more hours, resulted in a 5.4% increase in monthly migraine days. “Having a standardized definition for a migraine day is cri...

May 15, 2023

In a big-data analysis of 25 acute migraine medications, triptans, ergots, and anti-emetics emerged as the most effective medications. In a big-data analysis simultaneously comparing 25 acute m...

May 15, 2023

In ELEVATE, atogepant was effective in preventing difficult-to-treat episodic migraine among patients with previous failure of multiple preventive medications. Atogepant is an oral calcitonin g...

May 15, 2023

Anxiety and depression are the most common psychiatric comorbidities in migraine, but their impact on the risk of developing migraine and their gender and age differences are unclear, and research on ...

May 08, 2023

Zavegepant nasal spray was effective for acute migraine, demonstrating onset of efficacy as early as 15 minutes post-dose and a favorable safety profile. Non-oral acute therapies for migraine a...

May 08, 2023

The gut-brain axis describes a complex bidirectional association between neurological and gastrointestinal (GI) disorders. In patients with migraine, GI comorbidities are common. We aimed to evaluate ...

May 08, 2023

Approximately 80% of patients with migraine report light sensitivity during attacks and almost half report that following headache, light sensitivity is the most bothersome symptom. Light wavelengths ...

May 03, 2023

Migraine may represent a risk factor for benign paroxysmal positional vertigo and could explain why some cases of vertigo occur in younger patients. Benign paroxysmal positional vertigo (BPPV) ...

May 01, 2023

Migraine affects more than 4.5 million people in Spain, resulting in a considerable socioeconomic impact. Although national and international guidelines have been published, the management of patients...

May 01, 2023

Headache is a frequent reason for consultation between primary care physicians, emergency services physicians, and neurology specialists; however, it is not always well managed. The Andalusian Society...

Apr 24, 2023

Assess the clinical benefits and associated direct and indirect cost-savings from Remote Electrical Neuromodulation (REN) for migraine prevention.REN, a prescribed, wearable, FDA-cleared neuromodulati...

Apr 24, 2023

Persisting postconcussive symptoms (pPCS), particularly headache, can significantly disrupt children's recovery and functioning. However, the underlying pathophysiology of these symptoms remains uncle...